Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

参苓归元膏 - NMPA Drug Approval Details

Approvals/NMPA/Unknown Drug

Approved

中药

Unknown Drug

健民药业集团股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Sep 3, 2025
Approval ID: 7LeaeRcgexF
Company: 健民药业集团股份有限公司
Type: 中药

Approval Details

Approval Id: 7LeaeRcgexF
Approval Number: 国药准字B20020132
Generic Name: 参苓归元膏
Drug Type: 中药
Dosage Form: 煎膏剂（膏滋）
Strength: 每1克相当于饮片1.233克
Reg Date: 2025-09-03
Company Name: 健民药业集团股份有限公司
Company Address: 湖北省武汉市汉阳区鹦鹉大道484号
Production Company Name: 健民药业集团股份有限公司,健民集团叶开泰国药(随州)有限公司
Production Company Address: 湖北省武汉市汉阳区鹦鹉大道484号,湖北省随州高新技术产业园区
Company Detail Path: /organization/jianmin-pharmaceutical-group-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 3, 2025

Approval ID

7LeaeRcgexF

Type

中药

Back to NMPA Approvals